Mode
Text Size
Log in / Sign up
N/A N=1,206

Epidemiology of Depression, Anxiety, and Cognitive Impairment

Depression · Anxiety · Cognitive Impairment

Enrolled (actual)
1,206
Serious AEs
0.0%
Results posted
Jun 2015
Primary outcome: Primary: Participants With Depression by Patient Health Questionnaire - 9 — 177 participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
University of Rochester
Primary completion
Sep 2008

Outcome Measures

OutcomeResultp-value
PRIMARY
Participants With Depression by Patient Health Questionnaire - 9
177
PRIMARY
Participants With Cognitive Impairment by Six Item Screener
106
PRIMARY
Participants With Anxiety by Generalized Anxiety Disorder - 7
119
SECONDARY
Depression and Cognitive Impairment at 2 Weeks
27; 5

Summary

Many older adults have undetected health problems and lack basic prevention measures. Failure to identify and treat these conditions can lead to unnecessary morbidity and mortality and a decreased quality of life. Traditional screening and intervention programs, usually based in primary care providers' offices, have been insufficient, particularly in medically underserved populations. Alternate sites for screening and intervention have begun to receive attention and may hold promise. The emergency department (ED) is the entry point for access to medical and social services for many patients and has the potential to serve as a site to identify older adults with unmet needs. However, we do not know the prevalence of depression and cognitive impairment and how they differ by mode of arrival of the patient to the ED. Second, a question remains as to the validity of screening patients during an acute illness. Upon completion, this study will describe the epidemiology of the population of older adults presenting to the ED.

Eligibility Criteria

Inclusion Criteria

  • Age 60 and older
  • Arrival at ED

Exclusion Criteria

  • Institutionalized
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00717041). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search